Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis (Q83048054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

ankylosing spondylitis

1 reference

A Bal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Unlu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G Bahar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Aydog

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Eksioglu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R Yorgancioglu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

211-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

Serum levels of IL-1 beta, TNF-alpha, IL-8, and acute phase proteins in seronegative spondyloarthropathies

18 January 2020

cites work

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies

1 reference

12 December 2020

Elevated serum interleukin-2 receptor; increased in vitro immunoglobulin synthesis and lack of response to testosterone-enhanced in vitro interleukin-2 production in ankylosing spondylitis

1 reference

12 December 2020

Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies

1 reference

12 December 2020

Interleukin 1 and interleukin 2 generation by peripheral blood cells from patients with ankylosing spondylitis

1 reference

12 December 2020

Ankylosing spondylitis: the correlation between a new metrology score and radiology

1 reference

12 December 2020

Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review

1 reference

12 December 2020

Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis

1 reference

12 December 2020

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis

1 reference

12 December 2020

Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis

1 reference

12 December 2020

In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility

1 reference

12 December 2020

Etanercept: in ankylosing spondylitis

1 reference

12 December 2020

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis

1 reference

12 December 2020

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases

1 reference

12 December 2020

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

12 December 2020

Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity

1 reference

12 December 2020

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

12 December 2020

10.1007/S10067-006-0283-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16583185%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference